KRAS G12V

Clinical trials for KRAS G12V explained in plain language.

Never miss a new study

Get alerted when new KRAS G12V trials appear

Sign up with your email to follow new studies for KRAS G12V, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2

Engineered immune cells take aim at Hard-to-Treat KRAS cancers

Disease control Not yet recruiting

This early-phase study tests a personalized cell therapy called TCR-T in 25 adults with advanced solid tumors (like colorectal or lung cancer) that have specific KRAS mutations and haven't responded to standard treatments. The therapy uses the patient's own immune cells, engineer…

Matched conditions: KRAS G12V

Phase: EARLY_PHASE1 • Sponsor: Sun Yat-sen University • Aim: Disease control

Last updated May 17, 2026 03:16 UTC

KRAS G12V

Get alerted when new KRAS G12V trials appear

Engineered immune cells take aim at Hard-to-Treat KRAS cancers